An in vitro Absorption Model System Based on Cell Monolayers (Intestine 407, MDBK)

  • H. Leuenberger
  • S. Buchmann
  • C. Reinke
  • B. Schmid
Part of the NATO ASI Series book series (NSSA, volume 218)


Human in vivo studies on the physicochemical properties of drugs are difficult to perform, first of all because of ethic reasons. For similar reasons the number of animal tests should be reduced if possible. Therefore alternative methods are desired such as biological in vitro experiments based on cell cultures. Thus, the development of a suitable in vitro absorption model system based on defined cell monolayers may offer some advantages if the experiments are performed in very controlled conditions. This is an important precondition, because in vivo as well as in vitro biological experiments usually exhibit important variances in their results, i.e. relative standard errors around 30–40% are rather common. Many papers even present results without an estimate of the experimental error involved. With the in vitro absorption model system presented here, two goals can be pursued simultaneously: a possible reduction in the number of animal tests, such as e.g. in situ rat intestine perfusion experiments and hopefully a possible reduction of experimental error.


Salicylic Acid Cell Monolayer Permeability Coefficient Octanoic Acid Lipophilic Drug 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. [1]
    US-Patent 4,812, 407; europ. Pat. Appl. 0242326 and other Pat. Appl.Google Scholar
  2. [2]
    C. Barnes, Physics 5, 4 (1934) cited by G.L. Flynn, S.H. Yalkowsky and T.J. Roseman J. Pharm. Sci. 63, 479 (1974).CrossRefGoogle Scholar
  3. [3]
    V.G. Levich, Physicochemical Hydrodynamics; Prentice Hall, Englewood Clifts, N.J., 1962, p. 57–62.Google Scholar
  4. [4]
    J.A. Barrie, J.D. Levine, A.S. Michaels and P. Wong Trans. Faraday Soc. 59, 869 (1963).CrossRefGoogle Scholar
  5. [5]
    Q. Henle, F. Deinhardt, J. of Immunology 79, 54 (1957).Google Scholar
  6. [6]
    S.H. Madin and N.B. Darby, Proc. Soc. Exp. Biol. Med. 98, 574 (1958).PubMedGoogle Scholar
  7. [7]
    B. Schmid, H. Leuenberger, unpublished data.Google Scholar
  8. [8]
    T. Lindi, J. Bauer, Zell-und Gewebekultur, Gustav Fischer Verlag, Stuttgart, 1987, p. 151.Google Scholar
  9. [9]
    Ch. Watters, Analytical Biochemistry 88, 695 (1978).PubMedCrossRefGoogle Scholar
  10. [10]
    N.F.H. Ho, J.Y. Park, W. Morozowich and W.I. Higuchi, Physical model approach to the design of drugs with improved intestinal absorption, in Design of pharmaceutical properties through prodrugs and analogs, E.B. Roche, editor, American Pharmaceutical Association, Washington, D.C. 1977, p. 136–227.Google Scholar

Copyright information

© Plenum Press, New York 1991

Authors and Affiliations

  • H. Leuenberger
    • 1
  • S. Buchmann
    • 1
  • C. Reinke
    • 1
  • B. Schmid
    • 1
  1. 1.School of PharmacyUniversity of BaselBaselSwitzerland

Personalised recommendations